Medication Therapy Management (MTM) Practice Exam 2026 –
Graduate and Professional Certification Preparation in Medication
Reviews, Drug Therapy Problems, Patient Assessment, Care
Planning, Adherence, Pharmacotherapy Optimization and Clinical
Decision-Making
SECTION 1: FOUNDATIONS OF MEDICATION THERAPY MANAGEMENT (Questions 1-30)
Question 1
Which federal legislation first established Medication Therapy Management as a required
component of Medicare Part D?
A. Medicare Modernization Act of 2003
B. Affordable Care Act of 2010
C. Medicare Improvements for Patients and Providers Act of 2008
D. Health Insurance Portability and Accountability Act of 1996
Correct Answer: A
Explanation: The Medicare Modernization Act of 2003 created Medicare Part D and
mandated MTM programs for eligible beneficiaries with multiple chronic conditions and high
medication costs.
Question 2
A patient with diabetes, hypertension, and hyperlipidemia presents to the pharmacy. The
pharmacist identifies that the patient is taking seven medications and has questions about
adherence. This scenario BEST describes which component of MTM?
,A. Comprehensive medication review
B. Targeted medication review
C. Medication reconciliation
D. Adherence counseling
Correct Answer: A
Explanation: A comprehensive medication review involves a thorough assessment of all
medications, identifying medication-related problems, and addressing adherence concerns
across multiple chronic conditions.
Question 3
Which outcome is the PRIMARY goal of Medication Therapy Management services?
A. Reducing pharmacy dispensing errors
B. Optimizing therapeutic outcomes and reducing medication-related problems
C. Increasing pharmacy profitability
D. Reducing physician office visits
Correct Answer: B
Explanation: MTM aims to optimize medication therapy, improve patient outcomes, and
reduce adverse drug events through collaborative pharmacist-patient-prescriber
relationships.
Question 4
A Medicare Part D beneficiary qualifies for MTM services based on which set of criteria?
A. Single chronic condition and any medication count
,B. Multiple chronic diseases, multiple Part D medications, and annual medication costs
exceeding a threshold
C. Age over 65 regardless of health status
D. Annual income below poverty level
Correct Answer: B
Explanation: CMS requires MTM eligibility based on multiple chronic diseases, multiple
covered Part D drugs, and projected annual costs exceeding a specified threshold ($4,935 in
2023).
Question 5
The Core Elements of an MTM program include all of the following EXCEPT:
A. Medication therapy review
B. Personal medication record
C. Medication-related action plan
D. Physical examination and diagnosis
Correct Answer: D
Explanation: MTM core elements include medication therapy review, personal medication
record, medication-related action plan, intervention/referral, and documentation. Physical
examination is outside pharmacist scope in most MTM settings.
Question 6
During a comprehensive medication review, a pharmacist discovers a patient is taking two
NSAIDs concurrently. This is classified as what type of medication-related problem?
A. Unnecessary drug therapy
, B. Therapeutic duplication
C. Adverse drug reaction
D. Inappropriate dosing
Correct Answer: B
Explanation: Therapeutic duplication occurs when a patient receives multiple medications
from the same therapeutic class, increasing risk of adverse effects without added benefit.
Question 7
Which documentation format is MOST commonly used for MTM encounters?
A. SOAP note format
B. Narrative-only format
C. Triage note format
D. Discharge summary format
Correct Answer: A
Explanation: The SOAP (Subjective, Objective, Assessment, Plan) format is the standard
documentation method for MTM encounters, providing structured, comprehensive clinical
documentation.
Question 8
A pharmacist conducting an MTM review notices a patient's warfarin dose was recently
increased. Which laboratory value is MOST critical to review?
A. Serum creatinine
B. INR
Graduate and Professional Certification Preparation in Medication
Reviews, Drug Therapy Problems, Patient Assessment, Care
Planning, Adherence, Pharmacotherapy Optimization and Clinical
Decision-Making
SECTION 1: FOUNDATIONS OF MEDICATION THERAPY MANAGEMENT (Questions 1-30)
Question 1
Which federal legislation first established Medication Therapy Management as a required
component of Medicare Part D?
A. Medicare Modernization Act of 2003
B. Affordable Care Act of 2010
C. Medicare Improvements for Patients and Providers Act of 2008
D. Health Insurance Portability and Accountability Act of 1996
Correct Answer: A
Explanation: The Medicare Modernization Act of 2003 created Medicare Part D and
mandated MTM programs for eligible beneficiaries with multiple chronic conditions and high
medication costs.
Question 2
A patient with diabetes, hypertension, and hyperlipidemia presents to the pharmacy. The
pharmacist identifies that the patient is taking seven medications and has questions about
adherence. This scenario BEST describes which component of MTM?
,A. Comprehensive medication review
B. Targeted medication review
C. Medication reconciliation
D. Adherence counseling
Correct Answer: A
Explanation: A comprehensive medication review involves a thorough assessment of all
medications, identifying medication-related problems, and addressing adherence concerns
across multiple chronic conditions.
Question 3
Which outcome is the PRIMARY goal of Medication Therapy Management services?
A. Reducing pharmacy dispensing errors
B. Optimizing therapeutic outcomes and reducing medication-related problems
C. Increasing pharmacy profitability
D. Reducing physician office visits
Correct Answer: B
Explanation: MTM aims to optimize medication therapy, improve patient outcomes, and
reduce adverse drug events through collaborative pharmacist-patient-prescriber
relationships.
Question 4
A Medicare Part D beneficiary qualifies for MTM services based on which set of criteria?
A. Single chronic condition and any medication count
,B. Multiple chronic diseases, multiple Part D medications, and annual medication costs
exceeding a threshold
C. Age over 65 regardless of health status
D. Annual income below poverty level
Correct Answer: B
Explanation: CMS requires MTM eligibility based on multiple chronic diseases, multiple
covered Part D drugs, and projected annual costs exceeding a specified threshold ($4,935 in
2023).
Question 5
The Core Elements of an MTM program include all of the following EXCEPT:
A. Medication therapy review
B. Personal medication record
C. Medication-related action plan
D. Physical examination and diagnosis
Correct Answer: D
Explanation: MTM core elements include medication therapy review, personal medication
record, medication-related action plan, intervention/referral, and documentation. Physical
examination is outside pharmacist scope in most MTM settings.
Question 6
During a comprehensive medication review, a pharmacist discovers a patient is taking two
NSAIDs concurrently. This is classified as what type of medication-related problem?
A. Unnecessary drug therapy
, B. Therapeutic duplication
C. Adverse drug reaction
D. Inappropriate dosing
Correct Answer: B
Explanation: Therapeutic duplication occurs when a patient receives multiple medications
from the same therapeutic class, increasing risk of adverse effects without added benefit.
Question 7
Which documentation format is MOST commonly used for MTM encounters?
A. SOAP note format
B. Narrative-only format
C. Triage note format
D. Discharge summary format
Correct Answer: A
Explanation: The SOAP (Subjective, Objective, Assessment, Plan) format is the standard
documentation method for MTM encounters, providing structured, comprehensive clinical
documentation.
Question 8
A pharmacist conducting an MTM review notices a patient's warfarin dose was recently
increased. Which laboratory value is MOST critical to review?
A. Serum creatinine
B. INR
